Development of companion diagnostics shows no signs of slowing down anytime soon. As the field continues to grow, it is critical that the surrounding landscape progresses with it. Partnerships between pharmaceutical and diagnostic companies can lead to higher quality of care and better patient outcomes as medicine becomes increasingly personalized.
21-22 August 2023